Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab
– Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic dermatitis in Europe– Dermira to receive […]
– Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic dermatitis in Europe– Dermira to receive […]
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTCQB: BIOIF) […]
HONG KONG, Feb. 12, 2019 (GLOBE NEWSWIRE) — Verizon has expanded Secure Cloud Interconnect to allow its customers to privately […]
COLMAR, Pa., Feb. 11, 2019 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ:DORM) today announced the Company […]
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN […]
VANCOUVER, British Columbia, Feb. 11, 2019 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced […]
MONTERREY, Mexico, Feb. 11, 2019 (GLOBE NEWSWIRE) — Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known […]
VANCOUVER, British Columbia, Feb. 11, 2019 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” […]
TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) — North American Palladium Ltd. (“NAP” or the “Company”) (TSX:PDL) (OTC PINK:PALDF) today provided […]
CALGARY, Alberta, Feb. 11, 2019 (GLOBE NEWSWIRE) — Cardinal Energy Ltd. (“Cardinal” or the “Company“) (TSX: CJ) confirms that a […]